Most Recent

image: Stress-Induced Stem Cell Method Questioned

Stress-Induced Stem Cell Method Questioned

By | February 19, 2014

Researchers report difficulty replicating the results of studies touting a new method to reprogram stem cells.

6 Comments

image: Patent Granted for Fraudulent Science

Patent Granted for Fraudulent Science

By | February 17, 2014

The US Patent and Trademark Office has awarded patent protection to refuted discoveries on human stem cells.  

2 Comments

image: Week in Review: February 10–14

Week in Review: February 10–14

By | February 14, 2014

First Ancient North American genome; cannabinoids connect hunger with olfaction and eating; biotechs explore crowdfunding; confronting creationism

0 Comments

image: Pesticide Linked to Alzheimer’s

Pesticide Linked to Alzheimer’s

By | February 10, 2014

Researchers find that DDT may increase the risk of the neurodegenerative disease.

0 Comments

image: Triglyceride Clock

Triglyceride Clock

By | February 10, 2014

The timing of meals affects the levels of lipids in the livers of mice, according to a study.

0 Comments

image: Neural Target for Autism?

Neural Target for Autism?

By | February 7, 2014

Mouse and rat models of the developmental disorder responded positively to a drug given to their mothers a day before birth.

0 Comments

image: More Retractions for Fallen Scientist

More Retractions for Fallen Scientist

By | February 7, 2014

Molecular and Cellular Biology pulls five papers from endocrinologist Shigeaki Kato.

1 Comment

image: Not Seeing Is Hearing?

Not Seeing Is Hearing?

By | February 7, 2014

Hearing improves in mice deprived of visual stimulus for a week, according to a study.

0 Comments

image: Week in Review: February 3–7

Week in Review: February 3–7

By | February 7, 2014

Federal stem cell regulations vary; Salmonella exploit host immune system; microglia help maintain synaptic connections; prosthesis re-creates feeling of touch

0 Comments

image: Stem Cell Lines Not Fit for Clinic

Stem Cell Lines Not Fit for Clinic

By | February 6, 2014

Most stem cell lines registered with the NIH don’t comply with the FDA’s guidelines for human use, according to a new report.  

0 Comments

Popular Now

  1. Monsanto Buys Rights to CRISPR
    The Nutshell Monsanto Buys Rights to CRISPR

    The US agribusiness secures a global, nonexclusive licensing agreement from the Broad Institute to use the gene-editing technology for agricultural applications.

  2. How Plants Evolved Different Ways to Make Caffeine
  3. ESP on Trial
    Foundations ESP on Trial

    In the 1930s, parapsychologist Joseph Banks Rhine aimed to use scientific methods to confirm the existence of extrasensory perception, but faced criticisms of dubious analyses and irreproducible results.

  4. Another DNA Vaccine for Zika Shows Promise
RayBiotech